Results 131 to 140 of about 23,497 (215)

BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients. [PDF]

AIDS Res Treat
Pérez-Calvo F, Jover-Diaz F, Delgado-Sánchez E, Peris-García J, Bernabéu-Martínez MÁ.   +4 more
europepmc   +1 more source

Recent Developments in HIV Antivirals: The Prospect of Prophylactic Drugs to Change the Pandemic. [PDF]

Microb Biotechnol
Brüssow H.
europepmc   +1 more source

Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options. [PDF]

AIDS Res Ther
Fokam J, Anim-Keng TT, Pokam BT, Chenwi CA, Ka'e AC, Semengue ENJ, Beloumou Angong OEG, Takou D, Nka AD, Djupsa S, Etame NK, Molimbou E, Ajeh R, Bissek AZ, Colizzi V, Perno CF, Halle-Ekane GE, Ndembi N, Ndjolo A.   +18 more
europepmc   +1 more source

HIV drug resistance amongst children and adolescents with viraemia in Lesotho and Tanzania: a nested analysis in the GIVE MOVE trial. [PDF]

J Antimicrob Chemother
Schönenberger CM, Haenggi K, Ringera IK, Luoga E, Bresser M, Mothobi B, Mokhele K, Sando D, Molatelle M, Thahane L, Mnzava D, Ndege R, Hlasoa MM, Kayembe BP, Muhairwe J, Glass TR, Klimkait T, Weisser M, Labhardt ND, Tschumi N, Brown JA.   +20 more
europepmc   +1 more source

Quality of Life and Treatment Satisfaction in People with HIV Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Pooled Analysis from Observational Cohort Studies. [PDF]

Infect Dis Ther
Antinori A, Yokomaku Y, Elinav H, Pullukçu H, de Wet J, Antela A, Lu PL, Sabranski M, Kim YS, Bonnet F, den Hollander J, Jackson A, Choy CY, Cai W, Zhang F, Thorpe D, Marongiu A, Harrison R, Jarrett J, Boffito M.   +19 more
europepmc   +1 more source

Geographical and temporal trends of HIV-1 subtypes and drug resistance in China: a nationwide study over two decades (2003-2024). [PDF]

J Gen Virol
Xie B, Wang Z, Song Q, Cui M, Deng Y, Zheng F, Krol E, Khouri R, De Clercq E, Mo J, Li G.   +10 more
europepmc   +1 more source

Effectiveness of B/F/TAF in adults with HIV who are viremic with M184V/I. [PDF]

AIDS Res Ther
Rolle CP, D'Antoni ML, Corales R, Marongiu A, Gruber J, Schreibman T, Bell D, Hsiao CB, Brar I.   +8 more
europepmc   +1 more source

How should APOBEC3-induced resistance mutations be considered in the management of antiretroviral therapy? [PDF]

J Antimicrob Chemother
Gilbert M, Ferré VM, Guilbaud R, Digumber M, Peytavin G, Damond F, Le Hingrat Q, Yazdanpanah Y, Descamps D, Charpentier C, Joly V, Ghosn J.   +11 more
europepmc   +1 more source

Maternal Use of Integrase Strand Transfer Inhibitors During Pregnancy and Infant Neurodevelopment.

JAMA Netw Open
Williams PL, Boahene M, Mash LE, Chadwick EG, Huo Y, Spector SA, Oetting J, Garvie PA, Smith R.   +8 more
europepmc   +1 more source

Accelerated Combinatorial Drug Design for Human Immunodeficiency Virus Resistance through Seeded Multisite λ-Dynamics. [PDF]

J Chem Theory Comput
Bowling PE, Vilseck JZ, Brooks CL.
europepmc   +1 more source